Guggenheim
Upgrade grade
C
Downgrade grade
A
Guggenheim Partners, founded in 1927 as Guggenheim Grenfell & Co, has evolved into a diversified global investment banking and research powerhouse with approximately $290 billion in assets under management. The firm maintains a substantial equity research platform with roughly 2,917 analyst rating calls tracked across US equities, demonstrating significant coverage depth and analytical breadth across the market. Guggenheim is particularly renowned for its expertise in technology, telecommunications, healthcare, and financial services sectors, where its analysts have built strong reputations for deep industry knowledge and differentiated insights. The firm has distinguished itself through a strong institutional client base and a research culture that emphasizes bottom-up fundamental analysis, complemented by its integrated investment banking relationships that provide proprietary perspective on corporate strategy and M&A trends.
Upgrades
361
70.91% win rate
· avg +2.01% D1
Downgrades
377
78.78% win rate
· avg -4.79% D1
Avg Gap — Upgrades
+2.23%
open vs prev close
Avg Gap — Downgrades
-4.19%
open vs prev close
Performance by Sector
| Sector | ↑ Win% | ↑ D1 | ↓ Win% | ↓ D1 |
|---|---|---|---|---|
| Healthcare | 73.44% (64) | +4.10% | 78.16% (87) | -11.36% |
| Utilities | 61.67% (60) | -0.00% | 86.27% (51) | -2.34% |
| Energy | 72.73% (55) | +1.82% | 78.43% (51) | -1.60% |
| Financial Services | 76.00% (50) | +1.50% | 74.51% (51) | -2.97% |
| Consumer Cyclical | 70.00% (30) | +3.85% | 87.23% (47) | -3.40% |
| Technology | 79.49% (39) | +1.66% | 69.70% (33) | -4.71% |
| Communication Services | 70.59% (34) | +1.96% | 76.47% (34) | -2.53% |
| Consumer Defensive | 42.86% (14) | -0.72% | — | — |
| Industrials | — | — | 83.33% (12) | -3.14% |
Win Rate by Year
| Year | ↑ Win% | ↑ Calls | ↓ Win% | ↓ Calls |
|---|---|---|---|---|
| 2026 | 90.9% | 11 | 68.8% | 16 |
| 2025 | 88.5% | 26 | 83.3% | 24 |
| 2024 | 53.6% | 28 | 76.3% | 38 |
| 2023 | 72.2% | 36 | 63.9% | 36 |
| 2022 | 66.7% | 30 | 88.9% | 27 |
| 2021 | 73.9% | 23 | 100.0% | 27 |
| 2020 | 52.0% | 50 | 66.7% | 39 |
| 2019 | 74.2% | 31 | 79.5% | 44 |
| 2018 | 73.7% | 19 | 88.5% | 26 |
| 2017 | 75.0% | 24 | 89.5% | 19 |
Recent Calls
| Date | Ticker | Company | Sector | Action | Grade Change | PT | Gap | D1 |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | NOW | ServiceNow, Inc. | Technology | Upgrade | Neutral → Buy | $125 | +4.4% | +6.6% |
| Jul 1, 2026 | CRM | Salesforce, Inc. | Technology | Upgrade | Neutral → Buy | $228 | +3.5% | +4.2% |
| Jul 1, 2026 | CHKP | Check Point Software Technologies Ltd. | Technology | Upgrade | Neutral → Buy | $188 | +2.7% | +2.2% |
| Jun 25, 2026 | OKLO | Oklo Inc. | Utilities | Initiates | Neutral | — | +2.8% | -5.6% |
| Jun 16, 2026 | SPRB | Spruce Biosciences, Inc. | Healthcare | Initiates | Buy | $123 | +2.0% | -5.6% |
| Jun 11, 2026 | SEPN | Septerna, Inc. | Healthcare | Initiates | Buy | $52 | +1.3% | +11.7% |
| Jun 10, 2026 | PASG | Passage Bio, Inc. | Healthcare | Downgrade | Buy → Neutral | — | -2.0% | -7.9% |
| Jun 10, 2026 | BNTC | Benitec Biopharma Inc. | Healthcare | Downgrade | Buy → Neutral | — | -5.6% | -3.9% |
| Jun 8, 2026 | FRVO | — | — | Initiates | Buy | $48 | +3.7% | -8.8% |
| Jun 8, 2026 | CLYM | Climb Bio, Inc. | Healthcare | Initiates | Buy | $35 | +4.7% | +2.1% |
| Jun 4, 2026 | IRD | Opus Genetics, Inc. | Healthcare | Initiates | Buy | $16 | +3.3% | +10.5% |
| Jun 1, 2026 | ZS | Zscaler, Inc. | Technology | Upgrade | Neutral → Buy | $214 | +3.4% | +11.4% |
| May 28, 2026 | OCTV | — | — | Initiates | Buy | $30 | -0.2% | -2.5% |
| May 28, 2026 | JACK | Jack in the Box Inc. | Consumer Cyclical | Downgrade | Buy → Neutral | — | -4.2% | -1.9% |
| May 27, 2026 | DAVA | Endava plc | Technology | Downgrade | Buy → Neutral | — | -3.4% | +1.9% |
| May 26, 2026 | AVLN | — | — | Initiates | Buy | $80 | +2.9% | -7.4% |
| May 22, 2026 | AMRC | Ameresco, Inc. | Industrials | Reiterates | Neutral | — | -1.4% | +5.1% |
| May 21, 2026 | OCS | Oculis Holding AG | Healthcare | Initiates | Buy | $75 | +3.9% | +11.1% |
| May 19, 2026 | XE | X-Energy, Inc. Class A Common Stock | Industrials | Initiates | Buy | $57 | +2.9% | +4.6% |
| May 19, 2026 | STUB | StubHub Holdings, Inc. | Technology | Upgrade | Neutral → Buy | $12 | +5.7% | +2.3% |
| May 18, 2026 | YSWY | Yesway, Inc. | — | Initiates | Buy | $30 | -2.4% | -2.2% |
| May 13, 2026 | DT | Dynatrace, Inc. | Technology | Downgrade | Buy → Neutral | — | -14.5% | -11.4% |
| May 13, 2026 | MTZ | MasTec, Inc. | Industrials | Upgrade | Neutral → Buy | $480 | +2.6% | +0.8% |
| May 12, 2026 | ELVN | Enliven Therapeutics, Inc. | Healthcare | Initiates | Buy | $80 | +2.7% | +6.8% |
| May 11, 2026 | CHRS | Coherus Oncology, Inc. | Healthcare | Initiates | Buy | $12 | +8.0% | +11.4% |